AU2003276994A1 - Use of ribavirin for producing a pharmaceutical composition directed against bunyaviridae - Google Patents

Use of ribavirin for producing a pharmaceutical composition directed against bunyaviridae

Info

Publication number
AU2003276994A1
AU2003276994A1 AU2003276994A AU2003276994A AU2003276994A1 AU 2003276994 A1 AU2003276994 A1 AU 2003276994A1 AU 2003276994 A AU2003276994 A AU 2003276994A AU 2003276994 A AU2003276994 A AU 2003276994A AU 2003276994 A1 AU2003276994 A1 AU 2003276994A1
Authority
AU
Australia
Prior art keywords
bunyaviridae
ribavirin
producing
pharmaceutical composition
directed against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003276994A
Inventor
Ray Powles
Cornelius Sobel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biopartners GmbH Swiss
Original Assignee
BIOPARTNERS GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOPARTNERS GmbH filed Critical BIOPARTNERS GmbH
Publication of AU2003276994A1 publication Critical patent/AU2003276994A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003276994A 2002-06-18 2003-06-17 Use of ribavirin for producing a pharmaceutical composition directed against bunyaviridae Abandoned AU2003276994A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2002127148 DE10227148A1 (en) 2002-06-18 2002-06-18 Use of ribavirin for the manufacture of a pharmaceutical composition against Bunyaviridae
DE10227148.8 2002-06-18
PCT/EP2003/006392 WO2003105839A1 (en) 2002-06-18 2003-06-17 Use of ribavirin for producing a pharmaceutical composition directed against bunyaviridae

Publications (1)

Publication Number Publication Date
AU2003276994A1 true AU2003276994A1 (en) 2003-12-31

Family

ID=29719204

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003276994A Abandoned AU2003276994A1 (en) 2002-06-18 2003-06-17 Use of ribavirin for producing a pharmaceutical composition directed against bunyaviridae

Country Status (3)

Country Link
AU (1) AU2003276994A1 (en)
DE (1) DE10227148A1 (en)
WO (1) WO2003105839A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103977319A (en) * 2014-05-17 2014-08-13 王平 Traditional Chinese medicine composition for treating lower-limb phlebitis formation
CN103961617A (en) * 2014-05-30 2014-08-06 济南高达信息技术有限公司 External ointment for treating venous inflammation
CN104083592B (en) * 2014-07-28 2017-07-14 河南中医学院 A kind of Externally applied Chinese medicine liquid for treating phlebitis caused by chemotherapeutic medicines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20000066A1 (en) * 1997-12-22 2000-02-09 Schering Corp SOLID DOSAGE FORMS OF ORALLY ADMINISTRABLE RIBAVIRIN AND MANUFACTURING PROCESS

Also Published As

Publication number Publication date
DE10227148A1 (en) 2004-01-08
WO2003105839A1 (en) 2003-12-24

Similar Documents

Publication Publication Date Title
AU2003291103A1 (en) Pharmaceutical composition
AU2003278393A1 (en) New use for pharmaceutical composition
AU2003282345A1 (en) Photocurable composition containing maleide derivatives
AU2003250372A1 (en) Pharmaceutical composition
AU2003287639A1 (en) Methods of forming a supported activated catalyst composition
AU2003260803A1 (en) Sustained release pharmaceutical composition
AU2003236353A1 (en) Photopolymerizable composition
AU2003220968A1 (en) Anti-inflammatory agent
AU2003221699A1 (en) Pharmaceutical preparation for taste masking
AU2003213185A1 (en) Arylsulfone derivatives
AU2002314566A1 (en) Novel curcumin derivatives
AU2003215150A1 (en) Therapeutic compounds
AU2003289207A1 (en) Anti-inflammatory agent
AU2003282722A1 (en) Therapeutic compositions
AU2003284460A1 (en) Medicinal composition
AU2003276994A1 (en) Use of ribavirin for producing a pharmaceutical composition directed against bunyaviridae
AU2003208621A1 (en) A pharmaceutical composition
AU2003291642A1 (en) Pyrazoloazepine compounds as pharmaceutical agents
AU2003277581A1 (en) Resist composition
AU2003280799A1 (en) Medicinal composition
AU2002253441A1 (en) Medicaments containing glycerophosphoinositol-4-phosphate derivatives
AU2003222571A1 (en) Novel therapeutic application for a composition
AU2003279392A1 (en) Pharmaceutical compositions of azithromycin
AU2003221085A1 (en) Photocurable composition
AU2003280678A1 (en) Medicinal composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase